Immunosuppression Regimens
Immunosuppression Regimens is a clinical protocol that systematically combines pharmacologic agents to selectively inhibit immune system activity in organ transplant recipients, thereby preventing allograft rejection while balancing the risks of infection and toxicity.
2.1K
Publications
113.8K
Citations
12.1K
Authors
2.1K
Institutions
Publications per year
2017–2026
300
Variants
Immunosuppressive Regimens
2.1K
1–5 of 2.1K
12.1K
33
h-index
27
h-index
20
h-index
18
h-index
17
h-index
1–5 of 12.1K
2.1K
University of Pittsburgh
Pittsburgh, United States
43 h-index
368 publications
35.7K citations
Stanford University
Stanford, United States
37 h-index
206 publications
16K citations
University of Pittsburgh Medical Center
Pittsburgh, United States
36 h-index
254 publications
34.4K citations
Harvard University
Cambridge, United States
31 h-index
219 publications
12.2K citations
University of California, San Francisco
San Francisco, United States
29 h-index
112 publications
12.5K citations

Johns Hopkins University
Baltimore, United States
27 h-index
178 publications
14.4K citations

University of Minnesota
Minneapolis, United States
26 h-index
228 publications
17.7K citations
Medizinische Hochschule Hannover
Hanover, Germany
25 h-index
146 publications
6.1K citations
1–8 of 2.1K
494 publications · 32.9K citations
96
h-index
Repository · 269 publications · 10.2K citations
52
h-index
97 publications · 9.8K citations
51
h-index
87 publications · 2.8K citations
30
h-index
36 publications · 2.7K citations
28
h-index
1–5